These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28068979)

  • 1. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.
    Elidrissi Errahhali M; Elidrissi Errahhali M; Ouarzane M; El Harroudi T; Afqir S; Bellaoui M
    BMC Womens Health; 2017 Jan; 17(1):3. PubMed ID: 28068979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients.
    Alwan NAS; Mualla FH; Al Naqash M; Kathum S; Tawfiq FN; Nadhir S
    Gulf J Oncolog; 2017 Sep; 1(25):51-60. PubMed ID: 29019331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive breast cancer: a significant correlation between histological types and molecular subgroups.
    Caldarella A; Buzzoni C; Crocetti E; Bianchi S; Vezzosi V; Apicella P; Biancalani M; Giannini A; Urso C; Zolfanelli F; Paci E
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):617-23. PubMed ID: 23269487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.
    Bennis S; Abbass F; Akasbi Y; Znati K; Joutei KA; El Mesbahi O; Amarti A
    BMC Res Notes; 2012 Aug; 5():436. PubMed ID: 22889054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features.
    El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR
    Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.
    Alnegheimish NA; Alshatwi RA; Alhefdhi RM; Arafah MM; AlRikabi AC; Husain S
    Saudi Med J; 2016 May; 37(5):506-12. PubMed ID: 27146612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
    Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
    Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
    Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
    Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
    Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
    Llombart-Cussac A; Cortés J; Paré L; Galván P; Bermejo B; Martínez N; Vidal M; Pernas S; López R; Muñoz M; Nuciforo P; Morales S; Oliveira M; de la Peña L; Peláez A; Prat A
    Lancet Oncol; 2017 Apr; 18(4):545-554. PubMed ID: 28238593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.
    Gándara-Cortes M; Vázquez-Boquete Á; Fernández-Rodríguez B; Viaño P; Ínsua D; Seoane-Seoane A; Gude F; Gallego R; Fraga M; Antúnez JR; Curiel T; Pérez-López E; García-Caballero T
    Virchows Arch; 2018 Feb; 472(2):195-203. PubMed ID: 28825136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
    Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification of breast cancer: A retrospective cohort study.
    Al-Thoubaity FK
    Ann Med Surg (Lond); 2020 Jan; 49():44-48. PubMed ID: 31890196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco.
    El Fatemi H; Chahbouni S; Jayi S; Moumna K; Melhouf MA; Bannani A; Mesbahi O; Amarti A
    Diagn Pathol; 2012 Dec; 7():170. PubMed ID: 23216981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.